In the next models of mouse xenografts with FANCF-deficient and proficient ovarian cancer cell lines, the group observed NVB effectiveness especially on FANCF-deficient tumors when the vehicle had an impact on any of the cases. The gene discussed is FANCF; the disease is ovarian carcinoma.